| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 04/24/2008 | US20080092307 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride |
| 04/24/2008 | CA2664275A1 Crystalline form phthalazinone derivative for use in cancer treatment |
| 04/23/2008 | EP1497269B1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008014955A3 Fungicidal compounds and compositions |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090827 Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910298A2 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 04/16/2008 | EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 04/16/2008 | CN101163681A Phthalazinone derivative and pharmaceutical comprising the same |
| 04/10/2008 | WO2008041088A2 N-hydroxy benzamides with antitumor activity |
| 04/10/2008 | US20080085895 Substituted Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/09/2008 | EP1908754A1 Antibiotic maduraphthalazin salts with delayed release of the active substance and their use |
| 04/09/2008 | EP1908751A1 N-hydroxy benzamides with antitumour activity |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | CN101160289A Pyridazine derivatives and their use as therapeutic agents |
| 04/03/2008 | WO2008039999A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | CA2664364A1 Soluble epoxide hydrolase inhibitors |
| 04/02/2008 | EP1904455A2 Pyridazine derivatives |
| 04/02/2008 | EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101153074A Aromatic polyamide containing fluorine and diamine monomer containing fluorine based on naphthyridine ketone structure and method of producing the same |
| 04/01/2008 | US7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 03/27/2008 | WO2008034516A1 Antibiotic maduraphthalazin salts with delayed release of the active substance and their use |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 03/26/2008 | CN101151033A Preventive and/or therapeutic agent for rheumatoid arthritis |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | CA2173493C Fused pyridazine compounds |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070894 Anticancer agents; PLK1 inhibitors; PLK=polo-like kinase; imidazo(1,2-a)pyridines such as 5-bromo-4-[8-(difluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-1-phenylethyl]-2-pyrimidinamine |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/19/2008 | CN101146779A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/19/2008 | CN101146778A Method for producing 3,6-dichloropyridazine-1-oxide |
| 03/18/2008 | US7344702 Contrast agents for myocardial perfusion imaging |
| 03/13/2008 | WO2008030466A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/13/2008 | WO2007123939A8 Novel arylamino n-heteraryls as mek inhibitors |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/12/2008 | EP1896491A2 Monoazole ligand platinum analogs |
| 03/12/2008 | EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 03/12/2008 | EP1896394A1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/11/2008 | CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | CA2661842A1 Serine-threonine protein kinase and parp modulators |
| 03/05/2008 | EP1893597A2 Ampa receptor potentiators |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1575926B1 New pyridazin-3(2h)-one derivatives |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/04/2008 | US7338954 Compounds useful as motilin agonists and method |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023357A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| 02/28/2008 | US20080051420 New Compounds 317 |
| 02/28/2008 | US20080051409 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2661307A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| 02/27/2008 | CN101133042A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133037A 6-membered heterocyclic compound and use thereof |
| 02/26/2008 | US7335678 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor |
| 02/26/2008 | US7335658 Pyridazine derivatives and their use as therapeutic agents |
| 02/21/2008 | US20080045538 Nitro and amino substituted topoisomerase agents |
| 02/21/2008 | US20080045511 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | US20080039468 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/13/2008 | CN100368404C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/12/2008 | US7329770 Esters as useful broad spectrum herbicidal compounds |
| 02/12/2008 | US7329757 Chloroazinium compounds: 2-chloro-5-methyl-1-(3-trifluoromethyl-phenyl)-pyridinium chloride; intermediates for preparting iminoazine herbicides: N-cyclopropyl-5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridineimine |
| 02/07/2008 | WO2008016239A1 Caspase inhibitors based on pyridazinone scaffold |
| 02/07/2008 | US20080032988 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use |
| 02/07/2008 | US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 02/07/2008 | US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them |
| 02/07/2008 | US20080031823 Agents for therapy efficacy monitoring and deep tissue imaging |
| 02/07/2008 | CA2659571A1 Fungicidal compounds and compositions |
| 02/06/2008 | CN100366615C Reactive materials for limited play optical devices and methods of making same |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 02/05/2008 | CA2339272C Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same |
| 02/05/2008 | CA2313618C Transmucosal formulations of levosimendan |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 01/31/2008 | US20080027041 Pyridizinone derivatives |
| 01/31/2008 | CA2658821A1 Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors |